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Introduction / objectives
Curbing MRSA has been a challenge for our institution,
a hospital with hyperendemic MRSA since 1999.
Methods
An observational cohort study on MRSA trends was
prospectively carried out from 1993 onwards. Infection
control measures were initiated and intensified at var-
ious time points, including patient screening, surveil-
lance, contact isolation, a computerized alert system and
hospital-wide promotion campaign of hand hygiene. In
2003, the Vigigerm
® program was introduced, 2006 a
second promotion campaign of hand hygiene took place.
The MRSA burden had been recorded by indicators as
the proportion of MRSA among S. aureus in blood cul-
tures (expressed as percentage); validated on site surveil-
lance data of MRSA infected or colonized patients
expressed as incidence rates and MRSA incidence-den-
sity, expressed as acquired MRSA cases per 1000 hospi-
tal days.
Results
Two distinct periods could be observed. Increasing rates
of newly MRSA-infected or -colonized patients were
observed from 1989-1994 (from 0.05 to 0.6 cases per
100 admissions); by 1997 it has decreased to 0.24. Since
2000, there was a significant increase in the MRSA bur-
den, recorded by all indicators. This coincided with the
introduction of a highly epidemic clone (ST228 South
German). From 2000-2006 the incidence rate grew from
1.36 to 2.00 new cases per 100 admissions; with a pla-
teau between 2006 and 2008. It began to decrease by
2008 (from 1.70 to 1.12 new cases per 100 admissions).
The attack rate followed the same pattern (decline from
1.36 in 2007 to 0.70 acquired MRSA/1000 per hospital
days in 2010). Since 2000, the proportion of MRSA
among S. aureus in blood cultures stayed around 30%,
with a marked decrease in 2010 to 23%.
Conclusion
An ongoing intensive MRSA control program is neces-
sary to contain endemic MRSA rates.
Disclosure of interest
None declared.
Author details
1Infection Control Programme, Geneva, Switzerland.
2Genomics Research
Laboratory, University of Geneva Hospitals, Geneva, Switzerland.
Published: 29 June 2011
doi:10.1186/1753-6561-5-S6-P5
Cite this article as: Fankhauser et al.: Epidemiology of MRSA at the
University of Geneva Hospitals. BMC Proceedings 2011 5(Suppl 6):P5.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit 1Infection Control Programme, Geneva, Switzerland
Full list of author information is available at the end of the article
Fankhauser et al. BMC Proceedings 2011, 5(Suppl 6):P5
http://www.biomedcentral.com/1753-6561/5/S6/P5
© 2011 Fankhauser et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.